Vignesh Rajah's Insider Trades & SAST Disclosures
Vignesh Rajah's most recent trade in Y-Mabs Therapeutics Inc was a trade of 1,711 Common Stock done at an average price of $16.5 . Disclosure was reported to the exchange on March 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Vignesh Rajah.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 16.53 per share. | 05 Mar 2024 | 1,711 | 33,889 (0%) | 0% | 16.5 | 28,283 | Common Stock |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 35,700 | 35,700 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 17,800 | 35,600 (0%) | 0% | 0 | Common Stock | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 32,000 | 32,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 35,700 | 35,700 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 17,800 | 17,800 (0%) | 0% | 0 | Common Stock | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | Purchase of securities on an exchange or from another person at price $ 4.92 per share. | 15 Nov 2022 | 1,195 | 4,266 (0%) | 0% | 4.9 | 5,884 | Common Stock |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 32,000 | 32,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | Purchase of securities on an exchange or from another person at price $ 29.95 per share. | 12 Aug 2021 | 1,374 | 3,071 (0%) | 0% | 29.9 | 41,147 | Common Stock |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP and CMO | Purchase of securities on an exchange or from another person at price $ 45.74 per share. | 17 Nov 2020 | 1,464 | 1,464 (0%) | 0% | 45.7 | 66,963 | Common Stock |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP and CMO | Purchase of securities on an exchange or from another person at price $ 51.03 per share. | 17 Nov 2020 | 233 | 1,697 (0%) | 0% | 51.0 | 11,890 | Common Stock |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2020 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges